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Methods

Synthesis and characterization of PDS-p(SS-co-PEGMA).
Reversible additionfragmentation chain transfer (RAFT) polymerization was employed to copolymerize sodium 4-styrenesulfonate (SS) and poly(ethylene glycol) methyl ether methacrylate (PEGMA). 3-(Pyridin-2-yldisulfanyl)propyl-2-(ethylthiocarbonothioylthio) propanoate was used as the chain transfer agent (CTA). The polymerization was performed with an initial feed ratio of 0.038 mmol) were dissolved in 5 ml of Milli-Q water and 5 ml of DMF in a Schlenk tube. The system was sealed and subjected to four freeze-pump-thaw cycles before immersion in a 70 °C oil bath. Aliquots were removed at predetermined time points and diluted in D 2 O or DMF for 1 H NMR or GPC analysis, respectively. Conversions were calculated from the 1 H NMR spectra using the sum of the integral values of the vinylic protons of SS monomer and PEGMA monomer at 5.9 ppm and 6.2 ppm, respectively, and the sum of integral values of the regions where the monomer protons and the growing polymer protons overlap (7.8-6.3 ppm for SS and 4.0-3.2 ppm for PEGMA). The polymerization was stopped at 83% conversion. The polymer was purified by dialysis first with 1:1 v/v Milli-Q water:MeOH to remove residual monomer followed by dialysis with Milli-Q water (MWCO 8000) and lyophilized to remove solvent. 3448, 2924, 1718, 1647, 1453, 1410, 1181, 1122, 1035, 1008, 947, 832, 773, 671 . The M n = 26.1 kDa by NMR, 24.5 kDa by GPC, PDI = 1.16 by GPC. To remove the trithiocarbonate end group, the resulting polymer (42.7 mg, 1.6 x 10 -3 mmol) was combined with AIBN (13.48 mg, 0.08 mmol) in 10 ml of 1:1:1 v/v/v DMF:dioxane:MeOH in a Schlenk tube. The system was degassed by three freeze-pump-thaw cycles and stirred for 4.5
hours at 70 °C. The resulting PDS-p(SS-co-PEGMA) was purified by dialysis in 1:1 v/v Milli-Q water:MeOH followed by Milli-Q water (MWCO 8000) and lyophilized to remove solvent. UVvis spectrophotometry was used to monitor the disappearance of the trithiocarbonate group (λ = 309 nm). After radical exchange, M n = 26.0 kDa by GPC, PDI = 1.18 by GPC.
Quantification of pyridyl disulfide (PDS) end group retention.
To quantify the amount of PDS end group retention, PDS-p(SS-co-PEGMA) (1.43 mg, 2.74 x 10 -5 mmol) was dissolved in 1 ml of 0.1 M phosphate buffer (PB) pH 8.0. The volume was split into two halves. In one vial, 4.2 µl of 100 µg/µl of DTT in 0.1 M PB was added. The sample was diluted to 1 ml and allowed to incubate at 23 °C for 2 hours. In the second vial, the volume was brought to 1 ml with 0.1 M PB pH 8.0 without DTT to use as the control group. Absorbance of the by-product, pyridine-2-thione, at λ = 343 nm (ε = 8080 M -1 cm -1 in water) was assessed via UV-vis spectrophotometry.
Percentage of PDS end group retention was calculated using the formula:
where Abs 343 was the difference in absorbance between the sample (with DTT) and the control (without DTT) at λ = 343 nm. The experiment was repeated three times. The molecular weight of the polymer reported by NMR was used to determine the polymer concentration. 3045, 2974, 2923, 1732, 1573, 1561, 1446, 1417, 1388, 1370, 1268, 1154, 1106, 1083, 1043, 1010, 985, 860, 835, 804, 758, 733, 716 ml of MeOH were combined, sealed, and subjected to five freeze-pump-thaw cycles. In a twoneck round bottom flask, CuBr (51.2 mg, 0.36 mmol) and 2, 2'-bipyridine (111 mg, 0.71 mmol)
were combined and subjected to 4 vacuum-Ar refill cycles. An amount of 2 ml of degassed MeOH was added to the two-neck round bottom flask, and 0.5 ml of the mixture was transferred S7 to the Schlenk tube via syringe to start the polymerization. After 6 hours, air was bubbled through the reaction to stop the polymerization. The polymer was purified by dialysis against Gel electrophoresis. The collected fractions from conjugation were subjected to SDS-PAGE analysis. Samples were assessed under non-reducing conditions using NuPAGE ® 4-12%
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Bis-tris gels and MES SDS running buffer. The gel was run at 150 V, 200 mA for 40 minutes, fixed in gel fixing solution for 30 minutes, and then stained with iodine stain.
Western blot analysis. First, samples were assessed via SDS-PAGE or Native PAGE. For SDS-PAGE, the samples were first incubated with or without 54 mg/ml of dithiothreitol (DTT) for 3-5 minutes at 85 °C assessed similarly as described above. For Native PAGE, the samples were first prepared in the same manner, then assessed using Any kD™ Mini-PROTEAN® TGX™ precast gels with Tris-glycine as running buffer. The gels were run at 200 V for 30 minutes. After PAGE, the gels were transferred to nitrocellulose membranes (Whatman ® Protran BA 95 Nitrocellulose) at 100 V for 2 hours. The membranes were immediately blocked with 5%
fat-free dry milk containing 1% BSA (blocking solution) for 24 hours at 23 °C before incubation with rabbit anti-fibroblast growth factor basic antibody (1:20 dilution in blocking solution) at 4 °C for 16 hours. The membrane was washed by shaking in a Tris-buffered saline Tween-20
(TBST) solution for 3 of 10-minute cycles. Subsequently, the membrane was incubated with goat anti-rabbit IgG-HRP conjugate (1:1000 dilution in blocking solution) for 30 minutes at 23 °C.
After 3 x 10 minutes of washing in TBST, the membrane was developed for 5 minutes using SuperSignal ® West Pico Chemiluminescent Substrate (Thermo Scientific, Waltham) and exposed for 1-15 minutes on a FluorChem ® FC2 system. ). An average of 5-10 spectra per sample was obtained.
Electrospray ionization-gas-phase electrophoretic mobility molecular analysis (ESI-
Curve smoothing was accomplished using the moving average over 7 points in Excel. The EMD of the protein/conjugate was found from the maximum of the peak of interest. Molecular weights were calculated using the formula MW = V*d*N a , where d (in g/cm 3 ) is the effective density modeled to a sphere, N a is Avogadro's number, and V = (EMD) 3 *π/6. Lysozyme was used as the standard.
The ESI-GEMMA spectrum of bFGF (MW=16 kDa) showed a major peak at 4.45 nm corresponding to 16,116 Da when the average effective density for proteins (0.58 g/cm 3 ) was used in the calculation. 3 Effective densities of polymers and analytes in general vary depending on their composition and shape. 3, 4 They were determined experimentally for p(SS-co-PEGMA) and pPEGMA to be 0.90 g/cm 3 and 0.69 g/cm 3 , respectively (see Supplementary Fig. S1f, Fig.   S3e ). The effective densities of bFGF-p(SS-co-PEGMA) and bFGF-pPEGMA, assuming one protein linked to one polymer molecule, were 0.78 g/cm 3 and 0.64 g/cm 3 , respectively.
Employing these values, the experimental MWs of the bFGF-p(SS-co-PEGMA) and bFGFpPEGMA conjugates were 39 kDa and 30 kDa.
Cell culture. Human Dermal Fibroblast (HDF) primary cells were purchased from
PromoCell and cultured in PromoCell fibroblast growth medium containing 2% fetal calf serum, 1 ng/ml bFGF, 5 µg/ml insulin, supplemented with 100 unit/ml penicillin and 100 µg/ml streptomycin at 37 °C, 5% CO 2 . HDF cells were passaged every four days or after reaching 80%
confluency. HDF cells were used up to passage 12. BaF3 cells were kindly provided by Dr.
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David Ornitz and cultured as recommended. Specifically, the cells were grown in RPMI1640 medium containing 10% newborn bovine calf serum, 2 mM L-glutamine, 0.5 ng/ml of recombinant mouse IL-3, 600 µg/ml of G418, 50 nM of 2-mercaptoethanol, supplemented with 100 unit/ml penicillin and 100 µg/ml streptomycin at 37 °C, 5% CO 2 . The medium was changed every two days.
Cytotoxicity study. HDF cells were trypsinized and resuspended in fibroblast growth medium lacking bFGF. The cells were plated at a concentration of 5,000 cells/well in a 48-well plate and allowed to adhere over 16 hours at 37 °C, 5% CO 2 . Then, the medium in the wells was replaced with 200 µl of the working medium containing various amount of polymer or heparin.
After an incubation of 24 hours at 37 °C, 5% CO 2 , cell viability was assessed using Bioactivity study. HDF cells were trypsinized and resuspended in UltraCULTURE TM serum-free medium supplemented with 2 mM L-Glutamine, 100 unit/ml penicillin and 100 µg/ml streptomycin. The cells were plated at a concentration of 2,000 cells/well in a 96-well plate and allowed to adhere for 16 hours at 37 °C, 5% CO 2 . At the end of the 16-hour incubation, S11 an incubation of 72 hours at 37 °C, 5% CO 2 , CellTiter-Blue ® assay was carried out to evaluate cell proliferation. All experimental groups were normalized to the control group, which received only blank medium. Each group was done with six replicates.
Inhibition assay. HDF cells were plated at a concentration of 2,000 cells/well in a 96-well plate in the UltraCULTURE TM serum-free medium and allowed to adhere over 16 hours at 37 °C, 5% CO 2 . The experimental groups were prepared fresh to contain 1 ng/ml of bFGF, or 1 ng/ml of bFGF with 1 µg/ml of heparin, or 1 ng/ml of bFGF-p(SS-co-PEGMA); all with an addition of 125 nM of the inhibitor PD173074. (The optimum concentration of the inhibitor to inhibit cell growth was determined experimentally, see Supplementary Fig. S8 ). The control groups were the exact replicates with an exception of the addition of the inhibitor. The medium in the 96-well plate was replaced with 100 µl of each sample/well. After an incubation of 72 hours at 37 °C, 5% CO 2 , CellTiter-Blue ® assay was carried out to evaluate the extent of cell proliferation. All the groups were normalized to the blank, which only had the medium without the inhibitor. Each group was done with six replicates, and the whole experiment was repeated three times.
Proliferation assay of BaF3 cells. BaF3 cells were collected and washed three times with
cultured medium lacking IL-3. The cells were plated at the density of 20,000 cells/well/50 µL in a 96-well plate in the working medium. The samples were prepared in the working medium to contain 2 ng/ml of bFGF or bFGF-p(SS-co-pPEGMA), 2 ng/ml of bFGF with either 3 ng/ml of heparin, 2 µg/ml of heparin, 3 ng/ml of p(SS-co-pPEGMA), or 2 µg/ml of p(SS-co-pPEGMA).
Subsequently, 50 µL of each sample was added into each corresponding well. After an incubation for 42 hours at 37 °C, 5% CO 2 , CellTiter-Blue ® assay was carried out to evaluate the extent of cell growth. All of the groups were normalized to the control group, which had only S12 medium. Each group was performed with six replicates (see Supplementary Fig. S9 for results of all concentrations tested).
Statistical analysis. The data was presented as the average and the standard deviation or standard error of the mean (SEM) where SEM = STDEV/(n-1) 1/2 and n = the number of independent repeats. A two-way ANOVA was performed with sample groups and treatments as the two factors and found that the p values were 1 x 10 -46 and 4 x 10 -47 . Individual comparisons were made with Student's t-test. All tests were two-tailed, unpaired and p < 0.05 was considered significant. Table S1 . Analysis of the efficiency of the on-column conjugation of bFGF to PDS-p(SS-co-PEGMA). Quantification of bFGF in the collected fractions was performed using ELISA; the concentrations were extracted from the standard curve (below). The percent of bFGF in the 2 M NaCl fraction was calculated by the dividing the amount of bFGF in the 2 M NaCl fraction by the total amount of bFGF collected in all fractions. Percent yield was calculated by dividing the total bFGF collected in the 2 M fraction to the original amount of bFGF used for conjugation. CellTiter ® -Blue assay was performed to quantify the extent of cell growth. Data was normalized to the blank group (no bFGF added) in that same treatment set. Each sample was done with six repeats, and the whole experiment was repeated eight times including one blinded study, except (+)bFGF (+)1.5 ng/ml pPEGMA and (+)bFGFpPEGMA which were repeated four times, and the "pH 4.7 for 16 hrs" treatment set for other groups was repeated seven times. Error bars are SEM. Statistical analysis was done using two-way ANOVA and Student's t-test. * denotes p <0.05, ** denotes p < 0.01 and *** denotes p < 0.001 between the sample indicated and the (+) bFGF (-) heparin within that same stress set.
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Supplementary Data
Denotes no induced proliferation by bFGF. Figure S7 . Long-term stability study of bFGF-heparin-mimicking polymer conjugate, bFGF-p(SS-co-PEGMA), against storage at 4 °C. Preparation of the treated samples is the same as detailed in the Methods section of the paper, except that storage was 4 days, 1 week, 4 weeks, and 6 weeks. The concentrations of bFGF and bFGF conjugate under storage were 0.05 ng/µL. The final concentrations of bFGF and bFGF conjugate in the medium were 1 ng/ml. Incubation of 2,000-4,000 cells/well in 96-well plate with each of the samples was carried out for 72 hours. CellTiter ® -Blue assay was performed to quantify the extent of cell growth. Data showed the percent activity of each group relative to fresh bFGF. Each sample was done with six replicates. Error bars are standard deviations. Figure S8 . Screening for optimum concentration of the inhibitor PD173074 to inhibit HDF cells growth. Each sample group contained 1 ng/ml of bFGF except for the blank group. The x-axis shows increasing concentration of the PD173074 tested on HDF cells. 2,000 HDF cells/well was incubated with 100 µl of each of the samples for 72 hours. CellTiter ® -Blue assay was performed to quantify the extent of cell growth. Data was normalized to blank sample group. Each sample group was measured with six replicates. Error bars are standard deviations.
Denotes no induced proliferation by bFGF. . Proliferation study with BaF3 cells in response to the addition of the heparin-mimicking polymer and its bFGF conjugate. BaF3 cells (FR1C-11), which express FGFR1 but lack heparan sulfate proteoglycans, were seeded at a density of 20,000 cells/well in cultured medium lacking IL-3 in a 96-well plate. The samples were prepared in the working medium with the final concentrations: 1 ng/ml of bFGF, 1 ng/ml of bFGF with either 1.5 ng/ml or 1 µg/ml of heparin or with 1.5 ng/ml or 1 µg/ml of p(SS-co-PEGMA), and 1 ng/ml of bFGF-p(SS-co-PEGMA). The cells were incubated for 42 hours. CellTiter ® blue assay was performed to quantify the extent of cell growth. Data was normalized to blank sample group. Each group was done with six replicates. Error bars are standard deviations.
Denotes no induced proliferation by bFGF.
